Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Scott Gottlieb"


25 mentions found


Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHospitals have an IV fluid shortage due to the impact of Hurricane HeleneFormer FDA Commissioner Dr. Scott Gottlieb, joins 'Power Lunch' to discuss iV fluid shortage at hospitals and the hurricane impact on hospitals.
Persons: Hurricane Helene, Scott Gottlieb Organizations: Hospitals
The good news is that recent data suggests a decline in overdose deaths, the first significant drop in decades. Skyrocketing overdose deaths are nearly unavoidable, regardless of whether a state enforces tough penalties for drug possession or decriminalizes it. Since 2021, at least two-thirds of America’s 100,000 annual overdose deaths involved a synthetic opioid like fentanyl. Overdose deaths in the Northeast Deaths per 100,000 people Looking at regional overdose deaths shows this pattern clearly. It’s not coincidental that the exponential rise in overdose deaths has occurred in tandem with a profound increase in income inequality.
Persons: bartenders, skyrockets, didn’t Organizations: for Disease Control, National Forensic Laboratory Locations: East Coast, United States, America, East, Mississippi, Texas, Idaho, Oregon, New York City, Chicago, Rural West Virginia, Florida, West, U.S, Mexico
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Scott Gottlieb on obesity drug costs: Expect to see continued price reductionsFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the price of popular weight-loss drugs, whether steps can be taken to bring drug costs down, and more.
Persons: Scott Gottlieb Organizations: FDA
Here is a fact check:CrimeTrump claimed, “Our crime rate’s going through the roof.”Facts First: Trump’s claim is false. Facts First: Trump did express uncertainty about the number, but his “like 60 million or something” claim is false. They take ‘em out, and they bring them to the United States.”Facts First: Trump’s claim is baseless. He said, “With Ukraine, so we’re in for $250 billion and they’re in for about $71 billion.”Facts First: Trump’s claim is false. But Trump’s claim that the US has committed or provided far more aid than Europe is not true regardless.
Persons: Donald Trump, , Elon Musk, Kamala Harris, Trump, Jeff Asher, ” Anna Harvey, , we’ve, , Biden, Gary Griggs, Griggs, Harris, Harris “, ” Trump, wasn’t, Alejandro Mayorkas, Breitbart, ” Roberto Briceño, Venezuela’s, León, Joe Biden, ” Michelle Mittelstadt, can’t, Steven Cheung, Congo ’ Trump, Patrick Muyaya Katembwe, ” Serge Mombouli, Barack Obama’s, Obama, Obama’s, We’ll, Ukraine Trump, Europe Trump, Trump’s, Mike Pompeo, ” Pompeo, China, you’re, , Iran haven’t, ” Matt Smith, Biden’s, Smith, Ali Vaez, Ronald Reagan’s, Barack Obama, George W, they’d, Scott Gottlieb, ” Gottlieb, General Merrick Garland, Musk, Alvin Bragg’s, Matthew Colangelo, Colangelo, Bragg, CNN’s Tami Luhby, William Montes Organizations: Washington CNN, Republican, Democratic, Public, New York University, CNN, Major Cities Chiefs Association, Biden, Global, Trump, NASA, Meteorological Organization, University of California, Oceanic, Fox News, The New York, White, Homeland, Central, , Border, Venezuelan, of, Patrol, Republicans, Migration, Institute, Breitbart, Congo, PAC, Central America Trump, Obama, Customs Enforcement, Policy Institute, ICE, El Salvador, Electoral, Ukraine, Kiel Institute, European Union, European Automobile Manufacturers ’ Association, State, Americas, Crisis, Federal, Defense Department, Food and Drug Administration, FDA, Justice Department, New Locations: Trump’s, Santa Cruz, Gulf of Mexico, Florida, Mar, El Salvador, Guatemala, Honduras, United States, Mexico, Venezuela, “ Venezuela, Congo, Democratic Republic of Congo, Republic of Congo, Africa, Republic of, Washington, Europe, Ukraine, Germany, Kiel, , EU, Iran, Lebanon, Israel, China, that’s, Kpler, Malaysia, Afghanistan, Asia, Fulton County , Georgia, Manhattan, New York
The AI doctor will see you now: ChatGPT dominates medical exam
  + stars: | 2024-07-18 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe AI doctor will see you now: ChatGPT dominates medical examFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss which AI large language models (LLM) scored the highest in the same medical exam doctors have to answer to get a medical license, future of AI-powered healthcare,
Persons: Scott Gottlieb
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOzempic & Wegovy may be linked to eye condition, vision loss: StudyFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss a new study showing people taking Ozempic and Wegovy may be at an increased risk of developing an eye condition that can cause irreversible vision loss.
Persons: Scott Gottlieb
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFormer FDA Commissioner Dr. Scott Gottlieb on Supreme Court overturning the 1984 Chevron precedentFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to weigh in on the Supreme Court's decision to overturn the 1984 Chevron precedent and more.
Persons: Scott Gottlieb Organizations: Former, Chevron, FDA
Are PBMs driving drug prices up? Two analysts weigh in
  + stars: | 2024-06-28 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAre PBMs driving drug prices up? Two analysts weigh inCNBC’s Bertha Coombs with Dr. Scott Gottlieb and David Fields, join 'Power Lunch' to discuss pharmaceuticals stocks getting a slight tailwind from Biden's poor debate performance and PBMs driving drug prices up.
Persons: Bertha Coombs, Scott Gottlieb, David Fields
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Scott Gottlieb on protecting teens on social media: Ultimately parents need to get engagedFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the need for action against the dangers that social media poses to children, the likelihood of Congress mandating warning labels on social media apps similar to cigarettes and alcohol, what action parents can take, and more.
Persons: Scott Gottlieb
FDA advisers say Eli Lilly Alzheimer's treatment is effective
  + stars: | 2024-06-10 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFDA advisers say Eli Lilly Alzheimer's treatment is effectiveDr. Scott Gottlieb, Former FDA Commissioner, joins 'Closing Bell Overtime' to talk news that the FDA has deemed Eli Lilly's Alzheimers treatment as effective.
Persons: Eli Lilly Alzheimer's, Scott Gottlieb, Eli Lilly's Organizations: FDA
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFormer FDA Commissioner Dr. Scott Gottlieb on the rise of synthetic nicotineFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the rise of synthetic nicotine, the risks and regulation of products that use nicotine-like chemicals, avian-flu concerns, and more.
Persons: Scott Gottlieb Organizations: Former
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNestle announces Vital Pursuit frozen-food brand targeting GLP-1 usersFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss Nestle's new frozen food brand, whether Americans should eat this food, and more.
Persons: Scott Gottlieb Organizations: Nestle, FDA
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or betterFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss Amgen's new injectable weight loss drugs, how it takes a different approach from other weight loss drugs like Wegovy and Mounjaro, state of the obesity drug market, and more.
Persons: Gottlieb, Scott Gottlieb Organizations: FDA
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Scott Gottlieb on the AI drug revolution, bird flu cattle outbreak latestFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of Moderna's partnership with OpenAI to expand its employees access to AI chatbots, impact of the AI drug revolution, Dr. Gottlieb's venture into AI, latest developments on the bird flu cattle outbreak, and more.
Persons: Scott Gottlieb, OpenAI Organizations: FDA
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSome cancer drugs remain unproven 5 years after FDA's accelerated approval, study findsFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss a new study showing some cancer drugs fast racked by the FDA's accelerated approval program remain unproven 5 years after the approvals, news of bird flu spreading in dairy cows, how worried the public should be, and more.
Persons: FDA's, Scott Gottlieb
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe technology behind Neuralink's implants has promise: Former FDA Commissioner Dr. Scott GottliebFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the scrutiny over Neuralink's human trials, the technology behind the implants, approval of Merck's new treatment for a deadly lung condition, and more.
Persons: Scott Gottlieb
UnitedHealth Group said Monday that it's paid out more than $2 billion to help health-care providers who have been affected by the cyberattack on subsidiary Change Healthcare. "We continue to make significant progress in restoring the services impacted by this cyberattack," UnitedHealth CEO Andrew Witty said in a press release. "We know this has been an enormous challenge for health care providers and we encourage any in need to contact us." It also introduced a temporary funding assistance program to help health-care providers experiencing cash flow trouble because of the attack. A survey published by the American Hospital Association on Friday found that 94% of hospitals have experienced financial disruptions from the Change Healthcare attack.
Persons: it's, Andrew, UnitedHealth, Rick Pollack, Biden, UnitedHealth hasn't, Scott Gottlieb Organizations: UnitedHealth, Change Healthcare, Healthcare, Medicare, Medicaid Services, American Hospital Association, Administration, U.S . Department of Health, Human Services, Office, Civil Rights, Palo Alto Networks, Google Locations: Palo
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Scott Gottlieb on UnitedHealth hack: Very pervasive across the entire health care systemFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the latest developments on the UnitedHealth hack, the impact on the U.S. health care system, and more.
Persons: Scott Gottlieb Organizations: FDA
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFmr. FDA Commissioner weighs in on Medicare's involvement in GLP-1 pricesDr. Scott Gottlieb, Former FDA Commissioner, weighs in on the impact of GLP-1s on Medicare and the healthcare sector at large.
Persons: Scott Gottlieb Organizations: FDA, Medicare Locations: GLP
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFormer FDA commissioner: GLP-1 drugs are a profound medical advance on par with statinsDr. Scott Gottlieb, former FDA commissioner, joins 'Power Lunch' to discuss how big the GLP-1 drugs are likely to be, what could make the drugs hard for insurance not to pay for, and much more.
Persons: statins Dr, Scott Gottlieb Organizations: Former, statins, FDA
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email1 in 10 Americans are impacted by rare diseases 'it's a significant number', says NORD's SaltonstallPeter Saltonstall, NORD president and CEO, and Dr. Scott Gottlieb, former FDA commissioner, join 'Power Lunch' to discuss how you define what a rare disease is, how many people are affected by these rare diseases, and how costly the rare diseases are.
Persons: NORD's Saltonstall Peter Saltonstall, Scott Gottlieb Organizations: FDA Locations: NORD
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDOJ launches antitrust probe into UnitedHealth: Here's what to knowFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the DOJ's antitrust probe into UnitedHealth, why he believes the moves has been long overdue, and more.
Persons: Scott Gottlieb Organizations: DOJ, FDA
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFormer FDA Commissioner Dr. Scott Gottlieb on FTC's probe into drug shortagesFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the FTC's probe into the generic drug supply chain, following a shortage of medicines over the past year that has forced hospitals to ration drugs.
Persons: Scott Gottlieb Organizations: Former, FDA
The rise of 'Zynfluencers': What you need to know
  + stars: | 2024-02-08 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe rise of 'Zynfluencers': What you need to knowFormer FDA Commissioner Dr. Scott Gottlieb joins 'The Exchange' to discuss the health concerns about Zyn, how the product has captured the market, and more.
Persons: Scott Gottlieb Organizations: FDA
The $7 billion healthcare startup Ro, which has been prescribing brand-name weight-loss shots since January 2023, now offers compounded semaglutide to patients enrolled in its weight-management program. Nonetheless, Ro is the first prominent healthcare company to effectively endorse compounded semaglutide by prescribing it. A poor-quality compounded drug might simply be a dud and a waste of money. But while compounding pharmacies are subject to FDA and state regulations, states are the main regulators, and their oversight is patchy. Michael Siluk/UCG/Universal Images Group via Getty ImagesIt's hard to know if any given vial of compounded semaglutide is safe.
Persons: Wegovy's, Ro, drugmakers, Eli Lilly's, Eli Lilly's Mounjaro, Scott Gottlieb, Michael Siluk, That's, they've, Ozempic, Eli Lilly, Eric Kastango, they're, Kastango, aren't, Al Carter, Sarah Jones Simmer, Spencer Nadolsky, WeightWatchers, Tim Church, Wondr, it's, hasn't Organizations: Business, Novo Nordisk's Wegovy, US Food and Drug Administration, FDA, Novo Nordisk's Ozempic, Getty, Novo Nordisk, USP, National Association of, Pharmacy, Health Locations: Novo, Massachusetts, Austria, New York City
Total: 25